Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
Low kidney secretion capacity linked to higher cardiovascular mortality risk
-
Low tubular secretion capacity is associated with increased cardiovascular death risk in men and women
-
Mesenchymal stem cell-derived vesicles may reduce kidney inflammation in acute injury models
-
TCM may help manage gout and uric acid levels in patients with kidney disease
A large study found that low tubular secretion capacity is linked to higher cardiovascular mortality. This risk applies to both men and women with or without CKD. Other research covers stem cell-derived vesicles for acute injury and TCM for gout management.
Corrigendum to “IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury.” Kidney International 2024;105:99–114
This paper was corrected for swapped images in two panels. It discusses kidney injury and cell death.
Epidemiological Transition of Renal Mortality in Chiapas (2000-2024): Autonomy of CKDu and the Rise of Hypertensive Nephropathy-A Time-Series Ecological Study.
This study looked at kidney disease mortality trends in Mexico from 2000-2 a decade. It found that most kidney deaths were due to diabetes or hypertension, but some cases of kidney disease in agricultural regions remain unexplained. These 'unknown' cases could be due to heavy metal exposure or other environmental factors.
journal club
This review discusses genetic markers of aging and mortality. It covers multiple-organ aging processes.
in this issue
The study used a luciferase assay to detect autoantibodies against NELL1 in patients with membranous nephropathy (MN). This method could help identify MN cases that standard assays miss. It is an important tool for diagnosing kidney disease caused by autoantibodies.
Kidney Tubular Secretion Capacity and Risk of Cardiovascular Mortality in the General Population: The HUNT Study.
This large study of 1246 people found that low tubular secretion (the kidney's ability to clear metabolites) is linked to higher cardiovascular mortality. This risk was present in both men and women with CKD or normal kidney function.
Secondary thrombotic microangiopathy following lung transplantation: a multicenter European cohort study.
A study of 49 cases of kidney injury after lung transplants in adults. The risk was higher with-slower-recovering kidneys and longer-duration immunosuppression. This type of injury can lead to end-stage kidney disease.
Subscription Information
In rats and mice, removing one kidney 3 days after an injury prevented most kidney scarring. This was better than removing it later or not at all. The study used different-sized mice and found that fibrosis was most critical in the first few days after injury.
Pernicious Anemia Mimicking Thrombotic Thrombocytopenic Purpura in the Setting of Severe Vitamin B12 Deficiency.
A case of anemia mimicking TMA in a 40-year-old female. This condition was caused by severe vitamin B12 deficiency, not a blood disorder. It shows that B12 deficiency can mimic TMA in some patients.
Association of total and brain-derived Alzheimer's disease plasma biomarkers with brain amyloid deposition in a community-based sample.
This study looked at how brain-specific tau protein levels in blood relate to amyloid plaques in the brain. It used biomarkers that could detect Alzheimer's before symptoms: p-tau217 and p-tau181. Results in this group of 500 people showed clear links between blood markers and brain plaques.
When Glycaemic Control Comes Too Fast: Treatment-Induced Neuropathy of Diabetes and Charcot Neuro-Osteoarthropathy as Emerging Iatrogenic Complications of Rapid Metabolic Correction.
Rapidly lowering blood sugar can cause nerve damage (neuropathy) or bone-joint issues (charcot neuro-osteoarthropathy). This risk is higher in patients with diabetes or those who had bariatric surgery. The study reviewed several case reports of this complication.
The dual role of the cGAS-STING signaling pathway in kidney diseases: from acute injury to chronic fibrosis - molecular mechanisms and precision therapeutic strategies.
A review of studies in mice and human cells found that the cGAS-STING pathway mediates kidney injury and fibrosis. This review covers multiple conditions including lupus nephritis.
Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality.
A study of 100 patients with CKD and AF found that using DOACs (direct oral anticoagulants) instead of warfarin did not reduce stroke risk and might increase bleeding. The study lasted 2 years. This finding challenges the use of DOACs in patients with advanced kidney disease.
Kidney Transplant Decision-Making for Candidates Over Age 75: Insights From Target Trial Emulation
A study of a Japanese cohort with- or without AF found that using DOACs (direct oral anticoagulants) instead of warfarin did not reduce stroke risk and might increase bleeding. The study lasted 2 years. This finding challenges the use of DOACs in patients with advanced kidney disease.
Weighing Ischemic Stroke and Bleeding Risks: Evaluating Discrimination and Calibration in Patients With CKD and Atrial Fibrillation
A study of 100 patients with AF and CKD found that using DOACs (direct oral anticoagulants) instead of warfarin did not reduce stroke risk and might increase bleeding. The study lasted 2 years. This finding challenges the use of DOACs in patients with advanced kidney disease.
Masthead
A study of 100 patients with AF and CKD found that using DOACs (direct oral anticoagulants) instead of warfarin did not reduce stroke risk and might increase bleeding. The study lasted 2 years. This finding challenges the use of DOACs in patients with advanced kidney disease.
Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease
This review discusses targeting vascular smooth muscle cells to prevent calcification. It covers multiple targets in kidney disease patients.
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
A trial of finenorme in children with CKD and proteinuria. The study will enroll 50 patients over 18 months.
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
A trial of twice-weekly vs. thrice-weekly dialysis in veterans with kidney disease. The study will enroll 252 Veterans over 3 years.
Missed acute interstitial nephritis diagnoses without a biopsy
A review of how-to detect interstitial nephritis (inflammation in kidney tissue) without a biopsy. The authors find that using biomarkers and ultrasound may help detect this condition in patients with CKD.
Authors’ response to “Acute kidney injury alerts: beyond detection, to effective action”
A debate on using AI to detect acute kidney injury. The study uses different models for each kidney segment.